Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 21 Sept 2026 for Enliven Therapeutics, Inc., €52k. Read the official filing
Filing timeline
BuySaleBenjamin Hohl
Insider track record
Disclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Benjamin Hohl: trading record in brief
Benjamin Hohl discloses dealings in Enliven Therapeutics, Inc. to SEC (Form 4). The record holds 56 filings, for trades running from 22 December 2023 to 17 September 2026.
Sales make up the whole of the open-market record (15 sales, €1.1M). No amount is published for 3 filings, which the totals therefore leave out. Besides market trades, the filings include 1 share grant and 40 option exercises. 2026 to date brings no purchases and 14 sales.
The latest filing, published on 21 September 2026, reports an option exercise of €52k in Enliven Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Benjamin Hohl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations56 total
3,982 shares@ US$14.85Common StockSEC:0001882764-26-000008:0
3,535 shares@ US$50.0286Common StockSEC:0001882764-26-000008:1
2,194 shares@ US$50.7158Common StockSEC:0001882764-26-000008:2
289 shares@ US$51.4929Common StockSEC:0001882764-26-000008:3
4,630 shares@ US$58.35170.0062% mcap12.2% of flowCommon StockSEC:0001882764-26-000007:0
1,388 shares@ US$59.35360.0019% mcap3.7% of flowCommon StockSEC:0001882764-26-000007:1
123 shares@ US$53.87160.0002% mcap0.4% of flowCommon StockSEC:0001882764-26-000006:5
369 shares@ US$51.48230.0005% mcap1.0% of flowCommon StockSEC:0001882764-26-000006:2
324 shares@ US$49.97150.0004% mcap0.9% of flowCommon StockSEC:0001882764-26-000006:1
1,072 shares@ US$2.480.0001% mcap0.1% of flowCommon StockSEC:0001882764-26-000006:0
2,564 shares@ US$52.3180.0036% mcap7.3% of flowCommon StockSEC:0001882764-26-000006:3
2,638 shares@ US$53.38250.0038% mcap7.7% of flowCommon StockSEC:0001882764-26-000006:4
6,018 sharesCommon StockSEC:0001882764-26-000005:0
1,379 sharesCommon StockSEC:0001882764-26-000005:1
3,401 sharesCommon StockSEC:0001882764-26-000005:2
1,238 sharesCommon StockSEC:0001882764-26-000005:3
10,000 shares@ US$29.583942.5% of flowCommon StockSEC:0001882764-26-000002:0
25,000 shares0Common StockSEC:0001882764-26-000001:0
13,000 shares@ US$2.488.0% of flowCommon StockSEC:0001882764-25-000005:0
3,250 shares@ US$2.482.2% of flowCommon StockSEC:0001882764-25-000004:0
3,250 shares@ US$2.482.2% of flowCommon StockSEC:0001415889-25-023310:0
3,250 shares@ US$2.482.3% of flowCommon StockSEC:0001415889-25-020605:0
1,000 shares@ US$2.480.7% of flowCommon StockSEC:0001415889-25-019730:0
3,250 shares@ US$2.482.3% of flowCommon StockSEC:0001415889-25-018718:0
3,000 shares@ US$2.482.2% of flowCommon StockSEC:0001415889-25-017532:0
25 of 56 declarations
